- 150+ participants

- 26 countries represented

- CITIM 2009 was reviewed in in the J. Immunotoxicology, Future Oncology, and in the Targeted Proteins database developed by Current BioDataLtd (www.currentbiodata.com.) Brief conference review was also published by Thomson Reuters Scientific Division, Thomson Pharma (www.thomson-pharma.com) and Thomson Pharma Partnering (previously the IDdb; www.partnering.thomson-pharma.com)

- Selected presentations from CITIM 2009 participants were published in the Journal of Immunotoxicology.

- CITIM 2009 primary organizers:

          Michael R. Shurin, University of Pittsburgh, Pittsburgh, PA, USA

          Viktor Umansky, German cancer Research Center, Heidelberg, Germany

          Anatoli M. Malyguine, NCI-Frederick, Frederick, MD, USA